BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1517787)

  • 1. Acute monocytic or myelomonocytic leukemia with balanced chromosome translocations to band 11q23 after therapy with 4-epi-doxorubicin and cisplatin or cyclophosphamide for breast cancer.
    Pedersen-Bjergaard J; Sigsgaard TC; Nielsen D; Gjedde SB; Philip P; Hansen M; Larsen SO; Rørth M; Mouridsen H; Dombernowsky P
    J Clin Oncol; 1992 Sep; 10(9):1444-51. PubMed ID: 1517787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implication of prior treatment with drug combinations including inhibitors of topoisomerase II in therapy-related monocytic leukemia with a 9;11 translocation.
    Albain KS; Le Beau MM; Ullirsch R; Schumacher H
    Genes Chromosomes Cancer; 1990 May; 2(1):53-8. PubMed ID: 2177642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapy-related acute nonlymphocytic leukemia with monocytic features and rearrangement of chromosome 11q.
    DeVore R; Whitlock J; Hainsworth JD; Johnson DH
    Ann Intern Med; 1989 May; 110(9):740-2. PubMed ID: 2648930
    [No Abstract]   [Full Text] [Related]  

  • 4. Therapy-related acute myeloid leukemia following treatment with epipodophyllotoxins: estimating the risks.
    Smith MA; Rubinstein L; Ungerleider RS
    Med Pediatr Oncol; 1994; 23(2):86-98. PubMed ID: 8202047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapy-related myelodysplasia and acute myeloid leukemia. Cytogenetic characteristics of 115 consecutive cases and risk in seven cohorts of patients treated intensively for malignant diseases in the Copenhagen series.
    Pedersen-Bjergaard J; Philip P; Larsen SO; Andersson M; Daugaard G; Ersbøll J; Hansen SW; Hou-Jensen K; Nielsen D; Sigsgaard TC
    Leukemia; 1993 Dec; 7(12):1975-86. PubMed ID: 8255096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapy-related acute lymphoblastic leukaemia with MLL rearrangements following DNA topoisomerase II inhibitors, an increasing problem: report on two new cases and review of the literature since 1992.
    Andersen MK; Christiansen DH; Jensen BA; Ernst P; Hauge G; Pedersen-Bjergaard J
    Br J Haematol; 2001 Sep; 114(3):539-43. PubMed ID: 11552977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular rearrangements of the MLL gene are present in most cases of infant acute myeloid leukemia and are strongly correlated with monocytic or myelomonocytic phenotypes.
    Sorensen PH; Chen CS; Smith FO; Arthur DC; Domer PH; Bernstein ID; Korsmeyer SJ; Hammond GD; Kersey JH
    J Clin Invest; 1994 Jan; 93(1):429-37. PubMed ID: 8282816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment-related leukemia in breast cancer patients treated with fluorouracil-doxorubicin-cyclophosphamide combination adjuvant chemotherapy: the University of Texas M.D. Anderson Cancer Center experience.
    Diamandidou E; Buzdar AU; Smith TL; Frye D; Witjaksono M; Hortobagyi GN
    J Clin Oncol; 1996 Oct; 14(10):2722-30. PubMed ID: 8874333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment-related acute myelomonocytic leukemia with t(11;19) in a child following chemotherapy for hepatoblastoma.
    Koga Y; Matsuzaki A; Suminoe A; Washitoh N; Hara T; Hara T; Tajiri T; Taguchi T
    Pediatr Blood Cancer; 2008 Apr; 50(4):943-4. PubMed ID: 17973320
    [No Abstract]   [Full Text] [Related]  

  • 10. Therapy-related acute promyelocytic leukemia with t(15;17) (q22;q12) following chemotherapy with drugs targeting DNA topoisomerase II. A report of two cases and a review of the literature.
    Hoffmann L; Möller P; Pedersen-Bjergaard J; Waage A; Pedersen M; Hirsch FR
    Ann Oncol; 1995 Oct; 6(8):781-8. PubMed ID: 8589015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromosomal abnormalities in secondary MDS and AML. Relationship to drugs and radiation with specific emphasis on the balanced rearrangements.
    Andersen MK; Johansson B; Larsen SO; Pedersen-Bjergaard J
    Haematologica; 1998 Jun; 83(6):483-8. PubMed ID: 9676019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute myeloid leukemia with t(5;11): two case reports.
    Itoh M; Okazaki T; Tashima M; Sawada H; Uchiyama T
    Leuk Res; 1999 Jul; 23(7):677-80. PubMed ID: 10400190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapy-related leukemia cutis after adjuvant chemotherapy in a breast cancer patient.
    Lee HY; Ng HJ; Wong PC; Pang SM
    Acta Derm Venereol; 2010 Nov; 90(6):649-50. PubMed ID: 21057758
    [No Abstract]   [Full Text] [Related]  

  • 14. 11q23 aberration is an additional chromosomal change in de novo acute leukemia after treatment with etoposide and mitoxantrone.
    Ohshima A; Miura I; Chubachi A; Hashimoto K; Nimura T; Utsumi S; Takahashi N; Hayashi Y; Seto M; Ueda R; Miura AB
    Am J Hematol; 1996 Dec; 53(4):264-6. PubMed ID: 8948668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. t(8;16) AML developed subsequent to breast cancer therapy.
    Sahin FI; Yilmaz Z; Karakuş S; Boğa S; Akçali Z; DemIrhan B
    Hematology; 2006 Jun; 11(3):153-5. PubMed ID: 17326321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secondary acute myeloid leukemia following treatment with VP16-containing regimens for non-Hodgkin's lymphoma.
    Orlandi E; Lazzarino M; Bernasconi P; Astori C; Bernasconi C
    Haematologica; 1998 Aug; 83(8):758-9. PubMed ID: 9793267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Common region of ALL-1 gene disrupted in epipodophyllotoxin-related secondary acute myeloid leukemia.
    Felix CA; Winick NJ; Negrini M; Bowman WP; Croce CM; Lange BJ
    Cancer Res; 1993 Jul; 53(13):2954-6. PubMed ID: 8319201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Translocation t(11;19) (q23;p13) in a child with myelomonocytic leukemia following 2 years after chemotherapy for pneumoblastoma.
    Rialland X; Pein F; Saint-Andre JP; Flamant F
    Med Pediatr Oncol; 1993; 21(2):146-9. PubMed ID: 7679464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukemia in infants.
    Felix CA; Lange BJ
    Oncologist; 1999; 4(3):225-40. PubMed ID: 10394590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of acute leukemia following epirubicin-based adjuvant chemotherapy: a report from the National Cancer Institute of Canada Clinical Trials Group.
    Crump M; Tu D; Shepherd L; Levine M; Bramwell V; Pritchard K
    J Clin Oncol; 2003 Aug; 21(16):3066-71. PubMed ID: 12915595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.